We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tissue Processor for Routine Clinical Histopathology

By HospiMedica staff writers
Posted on 22 Dec 2006
A new tissue processor is a fully enclosed, stand-alone system that provides automated processing. More...
Designed for routine clinical histopathology, it is an innovative, smart processor for paraffin infiltration of up to 300 standard tissue cassettes.

Incorporating remote, contact-free fill and drain of reagents, the ASP300 S offers superior process control, an active paraffin cleaning cycle, and an improved reagent bottle and cabinet design, which are just a few of the features that ensure optimum specimen quality. The enhanced reagent-management system provides a consistently high sample quality with optimized reagent use. A compatibility-check algorithm avoids the cross contamination of incompatible reagents and assures a high level of safety and reliability. This extends the lifetime of the reagents and improves the sample quality.

The ASP300 S is produced by Leica Microsystems (Wetzlar, Germany) and is a significant improvement of Leica's ASP300. The overall focus of the design was to improve critical performance criteria like sample quality, process and operator safety, reagent carry-over and consumption, instrument up-time, and lifetime cost.

The Leica ASP300 S software allows immediate access to the various programs and guides the operator safely and smoothly through the system. Frequently used programs can be defined as "favorites.” A variety of smart features make the ASP300 S one of the most reliable and efficient instruments available for tissue processing. A context-sensitive, online help feature supports the operator in routine tasks and answers the most commonly asked questions about the use of the Leica ASP300 S. Operation is made very easy via a solvent-resistant color touch-screen.

The reagent management system assists the user in achieving the laboratory-quality target. All important data from each process are logged in a data file and can be printed out or downloaded on a disk. Context-sensitive help is available on-line to provide the necessary answers.

Functional features such as the optical level sensor system, a single-handed retort safety lock, the unique bottle clamping principle, an active wax clean, and fume extraction enhance both the performance and safety of the instrument.



Related Links:
Leica Microsystems

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.